Related Experiment Video
Updated: Feb 4, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Treatment for Recurrent Odontogenic Keratocysts
The odontogenic keratocyst (OKC), now classified as a benign tumor, presents treatment challenges. Aggressive resection proved necessary for two patients after conservative methods failed to prevent recurrence of these multicystic lesions.
Area of Science:
- Oral pathology
- Surgical oncology
- Dental medicine
Background:
- The odontogenic keratocyst (OKC) classification has evolved, now recognized as a benign tumor, sparking debate on optimal treatment strategies.
- Recurrence and patient morbidity remain significant concerns in managing OKC.
- Understanding the behavior of aggressive, multicystic OKCs is crucial for effective treatment planning.
Observation:
- Two cases of aggressive, multicystic odontogenic keratocysts (OKCs) are presented.
- Conservative treatment modalities were employed initially but failed to prevent lesion recurrence in both patients.
- The aggressive nature of the OKC in these cases necessitated a shift in treatment approach.
Findings:
- Conservative management of aggressive, multicystic odontogenic keratocysts (OKCs) can lead to treatment failure and recurrence.
- Surgical resection of aggressive, multicystic OKCs offers a better chance for definitive treatment and reduced morbidity.
- The study highlights the limitations of conservative approaches for certain OKC presentations.
Implications:
- Treatment decisions for odontogenic keratocysts (OKCs) require careful consideration of lesion aggressiveness and potential for recurrence.
- Surgical resection may be the preferred modality for aggressive, multicystic OKCs to ensure complete removal and minimize long-term complications.
- Further research into the biological behavior and optimal management of odontogenic keratocysts (OKCs) is warranted.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
05:25Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
Published on: October 24, 2025
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Angle Closure Glaucoma: Treatment